Trial · NCT03360747
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Change From Baseline to Month 3 in Fasting Triglycerides (TG) | AKCEA-ANGPTL3-LRx 20 mg | -550.00 | Standard Deviation 431.471 | mg/dL | |
| Percent Change From Baseline to Month 3 in Fasting Triglycerides (TG) | AKCEA-ANGPTL3-LRx 20 mg | -32.83 | Standard Deviation 31.994 | percent change | |
| Absolute Change From Baseline to Month 3 in Fasting Angiopoietin-Like 3 (ANGPTL3) | AKCEA-ANGPTL3-LRx 20 mg | -31.983 | Standard Deviation 5.4773 | ng/mL | |
| Percent Change From Baseline to Month 3 in Fasting Angiopoietin-like 3 (ANGPTL3) | AKCEA-ANGPTL3-LRx 20 mg | -51.249 | Standard Deviation 4.9093 | percent change | |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | Non-HDL-C | 217.33 | Standard Deviation 119.618 | mg/dL |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | ApoB | 64.53 | Standard Deviation 4.899 | mg/dL |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | HDL-C | 13.0 | Standard Deviation 1.00 | mg/dL |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | ApoA-1 | 77.3 | Standard Deviation 6.03 | mg/dL |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | VLDL-C | 190.17 | Standard Deviation 128.861 | mg/dL |
| Fasting Lipid and Lipoprotein Measurements at Month 3 | AKCEA-ANGPTL3-LRx 20 mg | LDL-C | 27.17 | Standard Deviation 10.324 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in TC | -86.17 | Standard Deviation 48.581 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3:Non-HDL-C | -83.83 | Standard Deviation 48.235 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in ApoB | -8.12 | Standard Deviation 5.352 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in HDL-C | -2.3 | Standard Deviation 0.58 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in ApoA-1 | -17.3 | Standard Deviation 11.93 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in VLDL-C | -82.50 | Standard Deviation 51.215 | mg/dL |
| Absolute Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | Absolute Change From Baseline to Month 3 in LDL-C | -1.33 | Standard Deviation 3.753 | mg/dL |
| Percent (%) Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | % Change From Baseline to Month 3 in TC | -30.39 | Standard Deviation 20.436 | percent change |
| Percent (%) Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | % Change From Baseline to Month 3 in Non-HDL-C | -31.49 | Standard Deviation 21.832 | percent change |
| Percent (%) Change From Baseline to Month 3 in Other Fasting Lipid Parameters | AKCEA-ANGPTL3-LRx 20 mg | % Change From Baseline to Month 3 in ApoB | -10.73 | Standard Deviation 6.021 | percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03360747/results